AI in the pharma R&D world isn’t just about designing better drugs against known drug targets, according to Aitia’s CEO, Colin Hill. Hear what Colin had to say on how powerful AI can be in understanding novel human causal biology, creating novel drugs, and enhancing patient selection in clinical trials. Full article on DPHARM, here.